Thematic photoMartin FalbisonerCC BY-SA 3.0Resized, encoded as WebP; displayed with responsive cropping under the original licenceSEC EDGAR published this disclosure on 2026-07-07. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001437749-26-022951
acquired disposedA
codeA
direct or indirectD
form4
is derivativefalse
issuer nameBIOLARGO, INC.
labelGrant or award
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001437749-26-022951",
"acquired_disposed": "A",
"code": "A",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "BIOLARGO, INC.",
"label": "Grant or award",
"person_name": "CODE KENNETH REAY",
"price": 0.1135,
"role": "Director, Chief Science Officer",
"security": "Common Stock",
"shares": 532567,
"shares_owned_after": 26408319,
"source_path": "edgar/data/880242/0001437749-26-022951.txt",
"ticker": "BLGO",
"value": 60446.3545
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.